ClinicalTrials.gg
Not yet recruitingNCT07247916CDA-2Updated Nov 9, 2026

Developing and Piloting an Implementation Strategy for a Brief, Motivational Interviewing-based Lethal Means Safety Counseling Intervention in Primary Care Settings

An interventional study of RAMP and Active control in Suicide Prevention, sponsored by VA Office of Research and Development. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Prevention

How we know

Updated Nov 9, 2026Eligibility revisedPrimary outcomes revisedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 20 studies in Suicide Prevention by VA Office of Research and Development — 11 open to participants now, 12 under way, none of them phase 3. Suicide Prevention · VA Office of Research and Development.

Planned enrollment
17th of 20
50 · median 120
Started
2027
with 2 others
No phase
18 of 20
9 open now
Primary completion
2029-07
later than 9 of 11 live
Registered
15th of 20
by date

Among the 20 studies in Suicide Prevention by VA Office of Research and Development, this one is the 17th largest by planned enrollment, is one of 3 that started in 2027, is one of 18 with no phase, reaches primary completion later than 9 of the 11 other live ones, and was the 15th registered.

Suicide Prevention

187 studies on the registry are indexed under Suicide Prevention; 92 are open to participants now.

Browse Suicide Prevention studies →

Open to participants now

11 of the 20 studies in Suicide Prevention by VA Office of Research and Development are open now, in 1 country. Recruiting first, the newest first:

5 more — sign in →

By country, each count listing its studies:

All 11 open studies →

Where they have run

Who these studies take

Of the 53 Suicide Prevention studies recruiting now, 28 (53%) set no upper age limit and 21 (40%) stop at 75 or younger; 25 take children under 18; 21 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 20 studies in Suicide Prevention by VA Office of Research and Development, or all of them as a file.
02

Study summary

Suicide prevention remains a significant priority and nearly three-quarters of Veteran suicides result from firearm injury. Since access to lethal means of self-harm increases the risk of injury, the VA/DoD Clinical Practice Guidelines recommend that Veterans with elevated suicide risk receive lethal means safety (LMS) counseling to reduce access to lethal means, including firearms. However, no LMS counseling interventions have been tested within VA. Thus, the aim of this study is to conduct a pilot randomized controlled trial to evaluate the feasibility and acceptability of a tailored LMS counseling intervention compared to an active control condition.

Read the detailed description

This is a pilot randomized controlled trial of up to 50 Veterans to assess the feasibility and acceptability of a LMS intervention and testing procedures.

03

Conditions studied

  • Suicide Prevention

Keywords

  • suicide
  • firearm
  • primary care
  • lethal means safety
  • motivational interviewing
  • self-injurious behavior
04

Who can participate

The criteria were revised on the registry on Nov 9, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

For Veterans:

  • Has access to a firearm
  • Referred to Primary Care Mental Health Integration (PCMHI) care

For clinicians (delivering intervention):

  • Deliver care in Primary Care Mental Health Integration (PCMHI)
  • Trained in RAMP and study procedures

Exclusion criteria

Exclusion Criteria:

For Veterans:

  • Unable to consent due to cognitive impairment, severity of illness (including psychiatric symptoms), intoxication with drugs and/or alcohol
  • Unreliable telephone access
  • Inability to read English or communicate in spoken and written English

For clinicians (delivering intervention):

- Did not participate in training

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    Active control

    The control condition will entail a 5-minute review of a pamphlet on suicide prevention with the Primary Care Mental Health Integration (PCMHI) clinician. This pamphlet is produced by the Veteran's Crisis Line and is widely available on the OSP suicide prevention website as a VHA resource. This condition will control for time and attention, subject matter, mode of delivery, and setting.

    Behavioral: Active control

  • Experimental
    RAMP

    Participants randomized to the intervention condition will receive a brief, motivational interviewing-based intervention called RAMP (Raise the subject, Assess current storage, Motivate change, and Plan next steps) in the context of their clinical care. RAMP incorporates evidence-informed intervention components to facilitate secure firearm storage

    Behavioral: RAMP

Interventions

  • BehavioralRAMP

    Participants randomized to the intervention condition will receive a brief, motivational interviewing-based intervention called RAMP (Raise the subject, Assess current storage, Motivate change, and Plan next steps) in the context of their clinical care. RAMP incorporates evidence-informed intervention components to facilitate secure firearm storage

  • BehavioralActive control

    The control condition will entail a 5-minute review of a pamphlet on suicide prevention with the Primary Care Mental Health Integration (PCMHI) clinician. This pamphlet is produced by the Veteran's Crisis Line and is widely available on the OSP suicide prevention website as a VHA resource. This condition will control for time and attention, subject matter, mode of delivery, and setting.

06

What researchers measure

Primary outcomes

  1. Screening

    Investigators will assess the number of new Primary Care Mental Health Integration (PCMHI) patients seen in PCMHI and the number who were approached about potential study participation per month

    Time frame: through study completion, approximately 2 years

  2. Recruitment

    Investigators will track the number of eligible Veterans who enrolled in the study per month

    Time frame: through study completion, approximately 2 years

  3. Retention

    Investigators will calculate the number of Veterans who received RAMP who were willing to complete immediate and one-month follow up assessments.

    Time frame: approximately 30 days

  4. Assessment of behavioral outcomes

    Investigators will assess the percentage of participants who completed behavioral outcome measures within the time allotted at each timepoint

    Time frame: approximately 30 days

  5. Veteran acceptability - Theoretical Framework of Acceptability

    Investigators will assess Veteran acceptability using the eight Likert-style items from the Theoretical Framework of Acceptability questionnaire, which assess seven component constructs of acceptability including Veteran's experience of the lethal means safety intervention. Each item has 5 answer options (1-5) on a Likert Scale. Score range is 8 to 40, with a higher score indicating more higher reported acceptability.

    Time frame: At immediate follow up, within approximately 2 weeks of intervention

  6. Veteran acceptability - Experience and Satisfaction with intervention

    Investigators will conduct qualitative evaluation of the participant's experience and satisfaction receiving the intervention.

    Time frame: At immediate follow up, within approximately 2 weeks of intervention

  7. Clinician acceptability - Theoretical Framework of Acceptability

    Investigators will invite clinicians to respond to the eight-item Theoretical Framework of Acceptability questionnaire eliciting clinician acceptability of the lethal means safety intervention. Each item has 5 answer options (1-5) on a Likert Scale. Score range is 8 to 40, with a higher score indicating more higher reported acceptability.

    Time frame: at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)

  8. Clinician acceptability - Negative impact

    Investigators will assess to what extent Primary Care Mental Health Integration (PCMHI) clinicians agree that study recruitment negatively impacted clinical care, using Likert-type items where '1' indicates "strongly disagree" and '5' indicates "strongly agree." For those responding \>3 ("don't know"), an open-ended question will elicit detailed information (e.g., interfered with delivery of clinical care, led to Veteran frustration).

    Time frame: at 50% enrollment (approximately 1 year) and 100% enrollment (approximately 2 years)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2027; primary completion for Jul 2029, 24 months later.

Of 129 non-industry interventional studies with no phase under Suicide Prevention, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 54. This study's planned 24 months is below that.

Counting every sponsor, half of 131 studies reached it within 28 months; a quarter within 12 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2025
First posted
Nov 25, 2025
StartEst.
Jul 1, 2027
Primary completionEst.
Jul 1, 2029
CompletionEst.
Dec 31, 2031
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Eligibility
2 inclusion criteria edited
What changed in the criteria
Inclusion criteria
  • EditedReferred to Primary Care Mental Health Integration (PCMHI) care
  • EditeddeliverDeliver care in Primary Care Mental Health Integration (PCMHI)
Nov 9, 2026
Primary outcomes
2 description edited
What changed in the outcomes
  • DescriptionClinician acceptability - Negative impact: how it is measured was reworded
  • DescriptionScreening: how it is measured was reworded
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    Eligibility 2 inclusion criteria edited
    What changed in the criteria
    Inclusion criteria
    • EditedReferred to Primary Care Mental Health Integration (PCMHI) care
    • EditeddeliverDeliver care in Primary Care Mental Health Integration (PCMHI)
    Primary outcomes 2 description edited
    What changed in the outcomes
    • DescriptionClinician acceptability - Negative impact: how it is measured was reworded
    • DescriptionScreening: how it is measured was reworded
    + 4 other changes: verification date, design details, arm descriptions and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07247916
Responsible party
Sponsor
First posted
Nov 25, 2025
Start date
Jul 1, 2027 (estimated)
Primary completion
Jul 1, 2029 (estimated)
Completion
Dec 31, 2031 (estimated)
Last update
Nov 9, 2026

Study contacts

Frances Aunon, PhD MS
Contact
Frances.Aunon@va.gov
(203) 932-5711 ext. 7894
Steve Martino, PhD
Contact
Steve.Martino@va.gov
(203) 932-5711 ext. 2468
Frances Aunon, PhD MS
principal investigator · VA Connecticut Healthcare System West Haven Campus, West Haven, CT

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion